Britain's National Health Service (NHS) will provide a cutting-edge gene therapy that aims to cure sickle cell disease, the ...

A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...

The Safe Life Organization Sargodha organised a blood donation camp for Thalassemia patients and screening camp at two ...

The Kashif Iqbal Thalassemia Centre (KITC) organised a daylong blood donation camp at Makli's Makhdoom Hashim Thattvi Park to ...

The gene therapy Casgevy, which will now be offered to some patients in England, could help people live disease-free, experts ...

Everything you need to know about agonising sickle cell disease and the ‘revolutionary’ new DNA therapy that's being rolled ...

For a school going child with thalassemia juggling the stress of monthly checkpoints with the hassle of monthly transfusions, the possibility of a permanent cure for the chronic condition is a ray of ...

The UK has approximately 17,500 individuals living with sickle cell disease, a condition particularly prevalent amongst those ...

NHS patients with sickle cell disease will be able to benefit from a groundbreaking gene-editing treatment that offers the prospect of a cure for the condition. The one-off gene therapy, known as ...

Vertex Pharmaceuticals Incorporated today announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVXtm (suzetrigine), an oral, non-opioid, highly selective NaV1.8 pain signal ...

January 31, 2025 expert reaction to NICE final draft guidance on exagamglogene autotemcel (exa-cel) for severe sickle cell disease . Scientists comment on final draft guidance fro ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVX™ (suzetrigin ...